Quick Answer
BioNexus Gene Lab Corp reported Research And Development Expense of $47.5 thousand for the year ending 2024.
- BioNexus Gene Lab Corp showed a decrease of -13.6% in Research And Development Expense from 2023 to 2024.
- This data is from BioNexus Gene Lab Corp's annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2024: $47.5 thousand | Fiscal year 2023: $55.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: